Skip to main content
Log in

Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia

Vasopressin als zusätzlicher Vasopressor bei vasodilatorischem Schock aufgrund einer nichtokklusiven mesenterialen Ischämie

  • Kasuistik
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Abstract

We present the case of an 83-year-old patient who underwent cardiac surgery and developed postoperative non-occlusive mesenteric ischemia (NOMI), which was treated with a local intra-arterial papaverine and prostaglandin E1 infusion. After successful mesenteric reperfusion, a multiple organ dysfunction syndrome with severe cardiovascular failure developed. High norepinephrine dosages (1.09 µg/kg body weight/min) and catecholamine-related complications (tachycardiac atrial fibrillation) required initiation of supplementary argininevasopressin (AVP) infusion (4 U/h). AVP stabilized vasodilatory shock, ensured adequate gut perfusion pressure and had no adverse clinical or angiographic effects on restitution of gut integrity. In conclusion, after reperfusion of NOMI in this patient, adjunct AVP therapy combined with local vasodilator infusion was beneficial as a potentially life-saving vasopressor.

Zusammenfassung

Wir berichten über einen 83-jährigen Mann, der nach einem kardiochirurgischen Eingriff eine nichtokklusive mesenteriale Ischämie (NOMI) entwickelte, die mit einer lokalen intraarteriellen Infusion mit Papaverin und Prostaglandin E1 behandelt wurde. Nach erfolgreicher mesenterialer Reperfusion entwickelte sich ein Multiorgandysfunktionssyndrom mit schwerem Herzkreislaufversagen. Hohe Noradrenalindosen (1,09 µg/kgKG/min) und katecholamininduzierte Komplikationen (tachykardes Vorhofflimmern) erforderten eine zusätzliche Arginin-Vasopressin- (AVP-)Infusion. Arginin-Vasopressin stabilisierte den vasodilatorischen Schock, sicherte einen adäquaten Perfusionsdruck des Darms und hatte keine negativen klinischen oder angiographischen Auswirkungen auf die Erholung der Darmintegrität. Zusammenfassend erwies sich bei diesem Patienten nach Reperfusion einer NOMI AVP in Kombination mit Noradrenalin und lokaler Vasodilatatorinfusion als potenziell lebensrettender Vasopressor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bone HG, Westphal M, Aken HC van (2002) Vasopressin – Not only good news! Crit Care Med 30:2604–2605

    Google Scholar 

  2. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31:946–955

    Article  PubMed  Google Scholar 

  3. Doguet F, Litzler PY, Tamion F (2004) Changes in mesenteric vascular reactivity and inflammatory response after cardiopulmonary bypass in a rat model. Ann Thorac Surg 77:2130–2137

    Article  PubMed  Google Scholar 

  4. Dunser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313–2319

    Article  PubMed  Google Scholar 

  5. Dunser MW, Wenzel V, Mayr AJ, Hasibeder W (2003) Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 63:237–256

    PubMed  Google Scholar 

  6. Eker A, Malzac B, Teboul J, Jourdan J (1999) Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as treatment? Eur J Cardiothorac Surg 15:218–220

    Article  PubMed  Google Scholar 

  7. Ernst S, Luther B, Zimmermann N, Bohner H, Wilke R, Feindt P, Furst G (2003) Current diagnosis and therapy of non-occlusive mesenteric ischemia. Rofo 175:515–523

    PubMed  Google Scholar 

  8. Giantomasso D di, May CN, Bellomo R (2002) Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804–1809

    Article  PubMed  Google Scholar 

  9. Harward TR, Brooks DL, Flynn TC, Seeger JM (1993) Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 18:459–469

    Article  PubMed  Google Scholar 

  10. Holmes CL, Walley KR (2004) Vasopressin in the ICU. Curr Opin Crit Care 10:442–448

    Article  PubMed  Google Scholar 

  11. Huwer H, Winning J, Straub U, Isringhaus H, Kalweit G (2004) Clinically diagnosed nonocclusive mesenteric ischemia after cardiopulmonary bypass: retrospective study. Vascular 12:114–120

    PubMed  Google Scholar 

  12. Klempnauer J, Grothues F, Bektas H, Wahlers T (1997) Acute mesenteric ischemia following cardiac surgery. J Cardiovasc Surg 38:639–643

    Google Scholar 

  13. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A (2003) High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 31:2646–2650

    Article  PubMed  Google Scholar 

  14. Klotz S, Vestring T, Rotker J, Schmidt C, Scheld HH, Schmid C (2001) Diagnosis and treatment of nonocclusive ischemia after open heart surgery. Ann Thorac Surg 72:1583–1586

    Article  PubMed  Google Scholar 

  15. Lock G, Scholmerich J (1995) Non-occlusive mesenteric ischemia. Hepatogastroenterology 42:234–239

    PubMed  Google Scholar 

  16. Malay MB, Ashton JL, Dahl K et al. (2004) Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 32:1327–1331

    Article  PubMed  Google Scholar 

  17. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E (2003) The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 97:1756–1763

    Article  PubMed  Google Scholar 

  18. Martinez MC, Vila JM, Aldasoro M, Medina P, Flor B, Lluch S (1994) Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br J Pharmacol 113:419–424

    PubMed  Google Scholar 

  19. Morelli A, Rocco M, Conti G et al. (2004) Effects of terlipressin on systemic and regional hemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 30:597–604

    Article  PubMed  Google Scholar 

  20. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576–582

    Article  PubMed  Google Scholar 

  21. Schutz A, Eichinger W, Breuer M, Gansera B, Kemkes BM (1998) Acute mesenteric ischemia after open heart surgery. Angiology 48:267–273

    Google Scholar 

  22. Silva E, Backer D de, Creteur J, Vincent JL (1998) Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 26:1749–1758

    Article  PubMed  Google Scholar 

  23. Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P (2002) Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol 12:1179–1187

    Article  PubMed  Google Scholar 

  24. Westphal M, Freise H, Kehrel BE, Bone HG, Aken H van, Sielenkamper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194–200

    Article  PubMed  Google Scholar 

Download references

Conflict of interest:

No information supplied.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Luckner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luckner, G., Jochberger, S., Mayr, V.D. et al. Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia. Anaesthesist 55, 283–286 (2006). https://doi.org/10.1007/s00101-005-0958-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-005-0958-3

Keywords

Schlüsselwörter

Navigation